Acrylamide inhibits terminal sprouting triggered by botulinum toxin type A in rats
CAI Hua-Ying,Xingyue Hu,JIANG Hong
2006-01-01
Abstract:AIM To evaluate if acrylamide can inhibit nerve terminal sprouting to prolong the muscle relaxation effect of botulinum toxin type A (BTXA). METHODS SD rats were divided randomly into normal, acrylamide, BTXA and BTXA+acrylamide groups. Right gastrocnemius of the rats was injected im BTXA 5 U in BTXA+acrylamide and BTXA groups and normal saline (NS, 0.2 mL) in acrylamide group. At d 3, 6, 9, 12, 15, 18 and 21 after injection of BTXA or NS, 3% acrylamide or NS (0.1 mL) was injected ip, respectively. At 1, 2, 3, 4, 6, 8, 10 and 12 weeks after im BTXA or NS, muscular power of right lower limb was scored by the method of Longa, et al, the fiber density and action potential mean consecutive difference of right gastrocnemius were examined by single fiber electromyogram, and the morphologic nerve fiber analysis was carried out. RESULTS After im BTXA, muscular power of right lower limb decreased; increased fiber density and morphologic nerve fiber analysis revealed terminal sprouting; and prolonged mean consecutive difference revealed abnormal function of neuromuscular junction; which almost recovered in 12 weeks after injection of BTXA. Acrylamide inhibited the nerve terminal sprouting number, postponed the peak time of nerve terminal sprouting, and delayed recovery of neuromuscular junction function. CONCLUSION Acrylamide inhibits both the terminal sprouting and the functional recovery of neuromuscular junction.